Sun Pharma falls most on Sensex, Nifty post Q4 earnings

Shares of Sun Pharma fell over 4 per cent today after the firm reported weak earnings for the quarter ended March 2022. The firm reported a consolidated net loss of Rs 2,277 crore in the last quarter, on account of a one-time exceptional loss.

Related Keywords

Mumbai ,Maharashtra ,India ,Sun Pharma , ,Un Pharma Stock Falls ,Sun Pharma Earnings ,Un Pharma Net Loss ,Un Pharma Profit ,